Aethlon Medical Inc (AEMD)

[Eitzenschild]

I really don't mind negative posts but

I do not understand Hopester. Analyzes technicals for days and then says the company is not worth investing in. I can't imagine spending so much time on a stock you won't touch. Hmmm

Efficacy tests indeed must have NO more delays. None of us understand whether efficacy trials are needed before any deal is possible or further compassionate use could be considered. But the false start with the prior lead researcher is one more setback.

The Lilly mention by Accesswire must be clarified or refuted. The IR contact a few weeks ago would neither confirm nor deny. Who else has spoken to them? What are the rules on something seemingly so material (or a bad rumor printed by a third party seemingly as fact)? At what point is the company obligated to clarify?

What have the newer large holders been told? It has to be more than the vague plans we've seen to this point.

India. Never explained why Hep C didn't take hold, acknowledged it wasn't the right path in hindsight but back we are for dengue. Is the HP really good on a mass basis? If so why not Hep C?

Sepsis is now going to be a complete surprise. More tests after September? No reason the Feds couldn't extend more. He was clear on the call we'll not be getting public guidance.